α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway
- PMID: 38615035
- PMCID: PMC11016063
- DOI: 10.1038/s41419-024-06630-9
α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway
Abstract
Cognitive dysfunction and dementia are critical symptoms of Lewy Body dementias (LBD). Specifically, alpha-synuclein (αSyn) accumulation in the hippocampus leading to synaptic dysfunction is linked to cognitive deficits in LBD. Here, we investigated the pathological impact of αSyn on hippocampal neurons. We report that either αSyn overexpression or αSyn pre-formed fibrils (PFFs) treatment triggers the formation of cofilin-actin rods, synapse disruptors, in cultured hippocampal neurons and in the hippocampus of synucleinopathy mouse models and of LBD patients. In vivo, cofilin pathology is present concomitantly with synaptic impairment and cognitive dysfunction. Rods generation prompted by αSyn involves the co-action of the cellular prion protein (PrPC) and the chemokine receptor 5 (CCR5). Importantly, we show that CCR5 inhibition, with a clinically relevant peptide antagonist, reverts dendritic spine impairment promoted by αSyn. Collectively, we detail the cellular and molecular mechanism through which αSyn disrupts hippocampal synaptic structure and we identify CCR5 as a novel therapeutic target to prevent synaptic impairment and cognitive dysfunction in LBD.
© 2024. The Author(s).
Conflict of interest statement
Dr. Michael Ruff has a financial interest in Creative Bio-Peptides, Inc. The remaining authors declare no competing interests.
Figures





Similar articles
-
Synaptic and cognitive impairment associated with L444P heterozygous glucocerebrosidase mutation.Brain. 2025 May 13;148(5):1621-1638. doi: 10.1093/brain/awae380. Brain. 2025. PMID: 39562000
-
Impact of hippocampal α-synuclein oligomers on cognitive trajectory in patients with dementia with Lewy bodies.Alzheimers Dement. 2025 Aug;21(8):e70374. doi: 10.1002/alz.70374. Alzheimers Dement. 2025. PMID: 40755115 Free PMC article.
-
Pathological α-synuclein elicits granulovacuolar degeneration independent of tau.Transl Neurodegener. 2025 Jun 19;14(1):31. doi: 10.1186/s40035-025-00494-5. Transl Neurodegener. 2025. PMID: 40537859 Free PMC article.
-
Alpha-synuclein seeding amplification assays in Lewy body dementia: a brief review.Mol Neurodegener. 2025 Jul 1;20(1):77. doi: 10.1186/s13024-025-00868-3. Mol Neurodegener. 2025. PMID: 40598304 Free PMC article. Review.
-
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Cochrane Database Syst Rev. 2012. PMID: 22419314 Free PMC article.
Cited by
-
Brain-derived extracellular vesicle microRNAs in Lewy body and Alzheimer's disease.bioRxiv [Preprint]. 2025 Jun 9:2025.06.06.656900. doi: 10.1101/2025.06.06.656900. bioRxiv. 2025. PMID: 40661348 Free PMC article. Preprint.
-
Chronic stress induces depression-like behaviors and Parkinsonism via upregulating α-synuclein.NPJ Parkinsons Dis. 2025 May 28;11(1):139. doi: 10.1038/s41531-025-00998-x. NPJ Parkinsons Dis. 2025. PMID: 40425616 Free PMC article.
-
Ellman's Assay on the Surface: Thiol Quantification of Human Cofilin-1 Protein through Surface Plasmon Resonance.Langmuir. 2024 Oct 1;40(39):20707-20714. doi: 10.1021/acs.langmuir.4c02792. Epub 2024 Sep 18. Langmuir. 2024. PMID: 39292813 Free PMC article.
-
The contributing role of CCR5 in dementia.Front Neurol. 2025 Jul 9;16:1545302. doi: 10.3389/fneur.2025.1545302. eCollection 2025. Front Neurol. 2025. PMID: 40703771 Free PMC article. Review.
-
Neuronal expression of S100B triggered by oligomeric Aβ peptide contributes to protection against cytoskeletal damage and synaptic loss.Front Mol Neurosci. 2025 Aug 8;18:1636365. doi: 10.3389/fnmol.2025.1636365. eCollection 2025. Front Mol Neurosci. 2025. PMID: 40861781 Free PMC article.